State of Illinois
92nd General Assembly
Legislation

   [ Search ]   [ PDF text ]   [ Legislation ]   
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ Engrossed ][ Enrolled ]
[ Senate Amendment 001 ][ Senate Amendment 004 ]


92_HB2463sam003

 










                                           LRB9206282ACacam01

 1                    AMENDMENT TO HOUSE BILL 2463

 2        AMENDMENT NO.     .  Amend House Bill 2463,  AS  AMENDED,
 3    by  replacing  everything  after the enacting clause with the
 4    following:

 5        "Section 5.  The Pharmacy Practice Act of 1987 is amended
 6    by changing Sections 3, 10, 14, 15, 18, 19, 22,  27,  and  30
 7    and adding Section 17.1 as follows:

 8        (225 ILCS 85/3) (from Ch. 111, par. 4123)
 9        (Section scheduled to be repealed on January 1, 2008)
10        Sec. 3. Definitions.  For the purpose of this Act, except
11    where otherwise limited therein:
12        (a)  "Pharmacy"  or  "drugstore" means and includes every
13    store,  shop,  pharmacy  department,  or  other  place  where
14    pharmaceutical care is provided by  a  pharmacist  (1)  where
15    drugs,  medicines,  or poisons are dispensed, sold or offered
16    for sale at retail, or displayed for sale at retail;  or  (2)
17    where  prescriptions  of physicians, dentists, veterinarians,
18    podiatrists,  or  therapeutically   certified   optometrists,
19    within  the limits of their licenses, are compounded, filled,
20    or dispensed; or (3) which has upon it  or  displayed  within
21    it,  or  affixed  to  or  used  in connection with it, a sign
22    bearing  the  word   or   words   "Pharmacist",   "Druggist",
 
                            -2-            LRB9206282ACacam01
 1    "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
 2    "Medicine  Store",  "Prescriptions", "Drugs", "Medicines", or
 3    any word or words of similar or like import,  either  in  the
 4    English  language  or  any  other  language; or (4) where the
 5    characteristic prescription sign (Rx) or  similar  design  is
 6    exhibited;  or  (5)  any  store, or shop, or other place with
 7    respect to which any of the above words,  objects,  signs  or
 8    designs are used in any advertisement.
 9        (b)  "Drugs"  means  and includes (l) articles recognized
10    in  the   official   United   States   Pharmacopoeia/National
11    Formulary  (USP/NF),  or  any  supplement  thereto  and being
12    intended for and having for their  main  use  the  diagnosis,
13    cure,  mitigation,  treatment or prevention of disease in man
14    or other animals, as approved by the United States  Food  and
15    Drug  Administration,  but  does not include devices or their
16    components, parts, or accessories; and (2) all other articles
17    intended for and having for their  main  use  the  diagnosis,
18    cure,  mitigation,  treatment or prevention of disease in man
19    or other animals, as approved by the United States  Food  and
20    Drug  Administration,  but  does not include devices or their
21    components, parts, or accessories; and  (3)  articles  (other
22    than  food)  having for their main use and intended to affect
23    the structure or any function of the body  of  man  or  other
24    animals;  and  (4)  articles  having  for  their main use and
25    intended for use as a component or any articles specified  in
26    clause (l), (2) or (3); but does not include devices or their
27    components, parts or accessories.
28        (c)  "Medicines"  means  and  includes all drugs intended
29    for human or veterinary use approved  by  the  United  States
30    Food and Drug Administration.
31        (d)  "Practice   of  pharmacy"  means  the  provision  of
32    pharmaceutical  care  to  patients  as  determined   by   the
33    pharmacist's  professional  judgment  in the following areas,
34    which  may  include  but  are  not  limited  to  (1)  patient
 
                            -3-            LRB9206282ACacam01
 1    counseling,  (2)  interpretation   and   assisting   in   the
 2    monitoring  of  appropriate  drug  use  and  prospective drug
 3    utilization  review,  (3)  providing   information   on   the
 4    therapeutic   values,   reactions,  drug  interactions,  side
 5    effects, uses, selection of medications and medical  devices,
 6    and  outcome  of  drug  therapy,  (4)  participation  in drug
 7    selection,  drug   monitoring,   drug   utilization   review,
 8    evaluation,  administration,  interpretation,  application of
 9    pharmacokinetic  and  laboratory  data  to  design  safe  and
10    effective drug regimens,  (5)  drug  research  (clinical  and
11    scientific),  and (6) compounding and dispensing of drugs and
12    medical devices.
13        (e)  "Prescription" means and includes any written, oral,
14    facsimile, or electronically transmitted order for  drugs  or
15    medical  devices,  issued by a physician licensed to practice
16    medicine in  all  its  branches,  dentist,  veterinarian,  or
17    podiatrist,  or therapeutically certified optometrist, within
18    the  limits  of  their  licenses, by a physician assistant in
19    accordance with  subsection  (f)  of  Section  4,  or  by  an
20    advanced  practice nurse in accordance with subsection (g) of
21    Section 4, containing the following: (l) name of the patient;
22    (2) date when prescription was issued; (3) name and  strength
23    of  drug or description of the medical device prescribed; and
24    (4) quantity, (5) directions for use, (6) prescriber's  name,
25    address and signature, and (7) DEA number where required, for
26    controlled  substances.  DEA numbers shall not be required on
27    inpatient drug orders.
28        (f)  "Person"  means  and  includes  a  natural   person,
29    copartnership,  association,  corporation, government entity,
30    or any other legal entity.
31        (g)  "Department" means the  Department  of  Professional
32    Regulation.
33        (h)  "Board of Pharmacy" or "Board" means the State Board
34    of Pharmacy of the Department of Professional Regulation.
 
                            -4-            LRB9206282ACacam01
 1        (i)  "Director"   means   the  Director  of  Professional
 2    Regulation.
 3        (j)  "Drug product selection" means the interchange for a
 4    prescribed pharmaceutical product in accordance with  Section
 5    25  of  this  Act and Section 3.14 of the Illinois Food, Drug
 6    and Cosmetic Act.
 7        (k)  "Inpatient drug order" means an order issued  by  an
 8    authorized prescriber for a resident or patient of a facility
 9    licensed  under  the  Nursing  Home  Care Act or the Hospital
10    Licensing Act, or "An Act in relation  to  the  founding  and
11    operation  of  the  University  of  Illinois Hospital and the
12    conduct of University  of  Illinois  health  care  programs",
13    approved  July  3,  1931,  as amended, or a facility which is
14    operated by the Department of Human Services (as successor to
15    the   Department   of   Mental   Health   and   Developmental
16    Disabilities) or the Department of Corrections.
17        (k-5)  "Pharmacist"   means   an   individual   currently
18    licensed by this State to engage in the practice of pharmacy.
19        (l)  "Pharmacist in charge" means the licensed pharmacist
20    whose  name  appears  on  a  pharmacy  license  and  who   is
21    responsible  for  all aspects of the operation related to the
22    practice of pharmacy.
23        (m)  "Dispense" means the delivery of drugs  and  medical
24    devices, in accordance with applicable State and federal laws
25    and   regulations,   to   the   patient   or   the  patient's
26    representative  authorized   to   receive   these   products,
27    including  the compounding, packaging, and labeling necessary
28    for delivery, and any recommending or advising concerning the
29    contents and therapeutic values and uses thereof.  "Dispense"
30    does not mean  the  physical  delivery  to  a  patient  or  a
31    patient's  representative  in  a  home  or  institution  by a
32    designee of a pharmacist or by  common  carrier.   "Dispense"
33    also does not mean the physical delivery of a drug or medical
34    device   to  a  patient  or  patient's  representative  by  a
 
                            -5-            LRB9206282ACacam01
 1    pharmacist's designee within a pharmacy  or  drugstore  while
 2    the pharmacist is on duty and the pharmacy is open.
 3        (n)  "Mail-order  pharmacy"  means  a  pharmacy  that  is
 4    located in a state of the United States, other than Illinois,
 5    that  delivers,  dispenses or distributes, through the United
 6    States Postal Service or other common  carrier,  to  Illinois
 7    residents, any substance which requires a prescription.
 8        (o)  "Compounding"   means   the   preparation,   mixing,
 9    assembling,  packaging,  or  labeling  of  a  drug or medical
10    device: (1) as the result of  a  practitioner's  prescription
11    drug  order  or  initiative  that  is dispensed pursuant to a
12    prescription in the course of professional practice;  or  (2)
13    for  the  purpose  of, or incident to, research, teaching, or
14    chemical analysis; or (3)  in  anticipation  of  prescription
15    drug  orders based on routine, regularly observed prescribing
16    patterns.
17        (p)  "Confidential   information"   means    information,
18    maintained  by  the  pharmacist  in  the  patient's  records,
19    released  only (i) to the patient or, as the patient directs,
20    to other practitioners and other pharmacists or (ii)  to  any
21    other person authorized by law to receive the information.
22        (q)  "Prospective   drug  review"  or  "drug  utilization
23    evaluation" means a  screening  for  potential  drug  therapy
24    problems   due   to   therapeutic  duplication,  drug-disease
25    contraindications, drug-drug interactions (including  serious
26    interactions with nonprescription or over-the-counter drugs),
27    drug-food  interactions, incorrect drug dosage or duration of
28    drug treatment, drug-allergy interactions, and clinical abuse
29    or misuse.
30        (r)  "Patient counseling" means the communication between
31    a  pharmacist  or  a  student  pharmacist  under  the  direct
32    supervision of a pharmacist and a patient  or  the  patient's
33    representative  about  the patient's medication or device for
34    the  purpose  of  optimizing  proper  use   of   prescription
 
                            -6-            LRB9206282ACacam01
 1    medications   or  devices.   The  offer  to  counsel  by  the
 2    pharmacist  or  the  pharmacist's  designee,  and  subsequent
 3    patient counseling by the pharmacist or  student  pharmacist,
 4    shall  be  made  in  a  face-to-face  communication  with the
 5    patient  or   patient's   representative   unless,   in   the
 6    professional  judgment  of  the  pharmacist,  a  face-to-face
 7    communication  is  deemed  inappropriate  or unnecessary.  In
 8    that instance, the offer to counsel or patient counseling may
 9    be made in a written communication, by  telephone,  or  in  a
10    manner determined by the pharmacist to be appropriate.
11        (s)  "Patient  profiles" or "patient drug therapy record"
12    means the obtaining, recording, and  maintenance  of  patient
13    prescription and personal information.
14        (t)  "Pharmaceutical  care"  includes, but is not limited
15    to, the act of monitoring drug use  and  other  patient  care
16    services  intended  to  achieve  outcomes  that  improve  the
17    patient's  quality  of life but shall not include the sale of
18    over-the-counter drugs by a seller of goods and services  who
19    does not dispense prescription drugs.
20        (u)  "Medical  device"  means  an  instrument, apparatus,
21    implement, machine, contrivance, implant, in  vitro  reagent,
22    or  other similar or related article, including any component
23    part or accessory, required under federal  law  to  bear  the
24    label  "Caution: Federal law requires dispensing by or on the
25    order of a physician". A seller of goods  and  services  who,
26    only  for  the  purpose  of  retail  sales, compounds, sells,
27    rents, or  leases  medical  devices  shall  not,  by  reasons
28    thereof, be required to be a licensed pharmacy.
29        (v)  "Unique  identifier"  means an electronic signature,
30    handwritten signature or  initials,  thumb  print,  or  other
31    acceptable  individual biometric or electronic identification
32    process as approved by the Department.
33    (Source: P.A. 89-202,  eff.  7-21-95;  89-507,  eff.  7-1-97;
34    90-116,  eff.  7-14-97;  90-253,  eff.  7-29-97; 90-655, eff.
 
                            -7-            LRB9206282ACacam01
 1    7-30-98; 90-742, eff. 8-13-98.)

 2        (225 ILCS 85/10) (from Ch. 111, par. 4130)
 3        (Section scheduled to be repealed on January 1, 2008)
 4        Sec. 10. State Board of Pharmacy. There is created in the
 5    Department the State Board of Pharmacy.  It shall consist  of
 6    9  members, 7 of whom shall be licensed pharmacists.  Each of
 7    those 7  members  must  be  a  licensed  pharmacist  in  good
 8    standing  in  this State, a graduate of an accredited college
 9    of pharmacy or hold a Bachelor of Science degree in  Pharmacy
10    and  have  at  least  5  years'  practical  experience in the
11    practice of pharmacy subsequent to the date of his  licensure
12    as  a  licensed  pharmacist  in the State of Illinois.  There
13    shall be 2 public members, who shall be voting  members,  who
14    shall  not be licensed pharmacists in this State or any other
15    state.
16        Each member shall be appointed by the Governor.
17        The terms of all members serving as  of  March  31,  1999
18    shall  expire  on  that  date.   The Governor shall appoint 3
19    persons to serve one-year terms, 3 persons  to  serve  3-year
20    terms,  and 3 persons to serve 5-year terms to begin April 1,
21    1999.  Otherwise, members shall be appointed to 5 year terms.
22    No member shall be eligible to serve more than 12 consecutive
23    years.
24        In making the appointment of members on  the  Board,  the
25    Governor  shall  give due consideration to recommendations by
26    the  members  of  the   profession   of   pharmacy   and   by
27    pharmaceutical  organizations  therein.   The  Governor shall
28    notify  the  pharmaceutical  organizations  promptly  of  any
29    vacancy of members on the Board  and  in  appointing  members
30    shall  give consideration to individuals engaged in all types
31    and settings of pharmacy practice.
32        The Governor may remove  any  member  of  the  Board  for
33    misconduct, incapacity or neglect of duty and he shall be the
 
                            -8-            LRB9206282ACacam01
 1    sole judge of the sufficiency of the cause for removal.
 2        Every  person  appointed a member of the Board shall take
 3    and subscribe the constitutional oath of office and  file  it
 4    with  the Secretary of State.  Each member of the Board shall
 5    be reimbursed for such actual and legitimate expenses  as  he
 6    may  incur  in  going  to  and  from the place of meeting and
 7    remaining thereat during sessions of the Board.  In addition,
 8    each member of the Board shall receive a per diem payment  in
 9    an  amount  determined  from time to time by the Director for
10    attendance at meetings of  the  Board  and  conducting  other
11    official business of the Board.
12        The  Board  shall  hold  quarterly meetings and an annual
13    meeting in January of each year and such  other  meetings  at
14    such  times  and places and upon such notice as the Board may
15    determine and as its business may require.  Five  members  of
16    the  Board  shall  constitute a quorum for the transaction of
17    business.  The Director shall appoint a pharmacy coordinator,
18    who shall be someone other than a member of the  Board.   The
19    pharmacy coordinator shall be a registered pharmacist in good
20    standing  in this State, shall be a graduate of an accredited
21    college of pharmacy, or hold  at  a  minimum  a  Bachelor  of
22    Science  degree  in Pharmacy and shall have at least 5 years'
23    experience in the practice of pharmacy immediately  prior  to
24    his  appointment.   The  pharmacy  coordinator  shall  be the
25    executive administrator and the chief enforcement officer  of
26    the Pharmacy Practice Act of 1987.
27        The  Board  shall  exercise the rights, powers and duties
28    which have been vested in the Board under this Act,  and  any
29    other duties conferred upon the Board by law.
30        The  Director  shall,  in  conformity  with the Personnel
31    Code, employ not less than 7  pharmacy  investigators  and  2
32    pharmacy  supervisors.   Each  pharmacy investigator and each
33    supervisor shall be a registered pharmacist in good  standing
34    in  this  State,  and  shall  be  a graduate of an accredited
 
                            -9-            LRB9206282ACacam01
 1    college of pharmacy and have at least 5 years  of  experience
 2    in  the  practice  of  pharmacy.    The Department shall also
 3    employ at least one attorney who is a pharmacist to prosecute
 4    violations of this Act and its rules.  The Department may, in
 5    conformity with the Personnel Code, employ such clerical  and
 6    other  employees  as are necessary to carry out the duties of
 7    the Board.
 8        The  duly  authorized  pharmacy  investigators   of   the
 9    Department  shall  have the right to enter and inspect during
10    business hours any pharmacy or any other place in  the  State
11    of  Illinois  holding  itself  out  to  be  a  pharmacy where
12    medicines or drugs or drug products or proprietary  medicines
13    are  sold,  offered  for  sale, exposed for sale, or kept for
14    sale.   The  pharmacy  investigators  shall   be   the   only
15    Department  investigators authorized to inspect, investigate,
16    and  monitor  probation  compliance   of   pharmacists,   and
17    pharmacies, and pharmacy technicians.
18    (Source: P.A. 91-827, eff. 6-13-00; 92-651, eff. 7-11-02.)

19        (225 ILCS 85/14) (from Ch. 111, par. 4134)
20        (Section scheduled to be repealed on January 1, 2008)
21        Sec. 14. Structural and equipment requirements. No person
22    shall establish or move to a new location any pharmacy unless
23    the  pharmacy is licensed with the Department and has on file
24    with the Department a verified statement that:
25             (1)  such pharmacy is or  will  be  engaged  in  the
26        practice of pharmacy; and
27             (2)  such  pharmacy  will  have  in  stock and shall
28        maintain sufficient drugs or and materials as to  protect
29        the public it serves within 30 days after the issuance of
30        the registration of the pharmacy.
31        Division  I,  II,  III, IV, or V pharmacies shall be in a
32    suitable, well-lighted and well-ventilated area with at least
33    300 square feet of clean and sanitary  contiguous  space  and
 
                            -10-           LRB9206282ACacam01
 1    shall  be  suitably  equipped  for compounding prescriptions,
 2    storage of drugs and sale of drugs and to  otherwise  conduct
 3    the  practice  of  pharmacy.   The  space  occupied  shall be
 4    equipped with a sink with hot and cold  water  or  facilities
 5    for   heating  water,  proper  sewage  outlet,  refrigeration
 6    storage equipment,  and  such  fixtures,  facilities,  drugs,
 7    equipment  and  material,  which  shall  include  the current
 8    editions of the United  States  Pharmacopoeia/DI,  Facts  and
 9    Comparisons,  or any other current compendium approved by the
10    Department, and other such reference works, as will enable  a
11    pharmacist  to  practice pharmacy, including this Act and the
12    rules promulgated under this Act.  Such pharmacy  shall  have
13    the following items: accurate weights of 0.5 gr. to 4 oz. and
14    20  mg  to  100  Gm; and a prescription balance equipped with
15    balance indicator and with mechanical means of arresting  the
16    oscillations  of  the  mechanism  and  which balance shall be
17    sensitive to 0.5 grain (32 mg)  or  less  or  an  alternative
18    weighing device as approved by the Department, and such other
19    measuring  devices as may be necessary for the conduct of the
20    practice of pharmacy.
21        The provisions of this Section with regard to 300  square
22    feet  of  space  shall  apply to any pharmacy which is opened
23    after the effective date of this Act.  Nothing shall  require
24    a  pharmacy  in  existence  on the effective date of this Act
25    which is comprised of less than 300 square  feet  to  provide
26    additional space to meet these requirements.
27    (Source: P.A. 90-253, eff. 7-29-97.)

28        (225 ILCS 85/15) (from Ch. 111, par. 4135)
29        (Section scheduled to be repealed on January 1, 2008)
30        Sec.  15. Pharmacy requirements. It shall be unlawful for
31    the owner of any pharmacy, as defined in this Act, to operate
32    or conduct the same, or to allow the same to be  operated  or
33    conducted, unless:
 
                            -11-           LRB9206282ACacam01
 1        (a)  It has a licensed pharmacist, authorized to practice
 2    pharmacy  in  this State under the provisions of this Act, on
 3    duty whenever the practice of pharmacy is conducted;
 4        (b)  Security provisions for all drugs  and  devices,  as
 5    determined by rule of the Department, are provided during the
 6    absence   from   the   licensed   pharmacy  of  all  licensed
 7    pharmacists.   Maintenance  of  security  provisions  is  the
 8    responsibility  of  the  licensed  registered  pharmacist  in
 9    charge; and
10        (c)  The pharmacy  is  licensed  under  this  Act  to  do
11    business.
12        The  Department  shall, by rule, provide requirements for
13    each division of pharmacy license and shall, as well  provide
14    guidelines  for the designation of a registered pharmacist in
15    charge for each division.
16        Division I.  Retail Licenses  for  pharmacies  which  are
17    open to, or offer pharmacy services to, the general public.
18        Division  II.   Licenses  for  pharmacies  whose  primary
19    pharmacy  service  is  provided  to  patients or residents of
20    facilities licensed under the Nursing Home Care  Act  or  the
21    Hospital  Licensing  Act,  or  "An  Act  in  relation  to the
22    founding and operation of the University of Illinois Hospital
23    and  the  conduct  of  University  of  Illinois  health  care
24    programs", approved July 3, 1931, as amended, and  which  are
25    not located in the facilities they serve.
26        Division  III.  Licenses for pharmacies which are located
27    in a facility licensed under the Nursing Home Care Act or the
28    Hospital Licensing  Act,  or  "An  Act  in  relation  to  the
29    founding and operation of the University of Illinois Hospital
30    and  the  conduct  of  University  of  Illinois  health  care
31    programs",  approved  July 3, 1931, as amended, or a facility
32    which is operated by the Department  of  Human  Services  (as
33    successor   to   the   Department   of   Mental   Health  and
34    Developmental Disabilities) or the Department of Corrections,
 
                            -12-           LRB9206282ACacam01
 1    and which provide pharmacy services to residents or  patients
 2    of  the  facility,  as  well  as  employees,  prescribers and
 3    students of the facility.
 4        Division IV.  Licenses for pharmacies  which  provide  or
 5    offer for sale radioactive materials.
 6        Division  V.  Licenses for pharmacies which hold licenses
 7    in Division II or Division III which  also  provide  pharmacy
 8    services  to  the  general  public,  or  pharmacies which are
 9    located in or whose primary pharmacy service is to ambulatory
10    care facilities or schools of veterinary  medicine  or  other
11    such institution or facility.
12        The  Director  may waive the requirement for a pharmacist
13    to be on duty at all times for State facilities not  treating
14    human ailments.
15        It  shall  be  unlawful  for  any  person,  who  is not a
16    licensed pharmacy or health care facility, to purport  to  be
17    such  or  to  use  in name, title, or sign designating, or in
18    connection with that place of business,  any  of  the  words:
19    "pharmacy",      "pharmacist",     "pharmacy     department",
20    "apothecary",  "druggist",  "drug",   "drugs",   "medicines",
21    "medicine store", "drug sundries", "prescriptions filled", or
22    any  list  of  words  indicating that drugs are compounded or
23    sold to  the  lay  public,  or  prescriptions  are  dispensed
24    therein.   Each  day  during  which,  or  a  part which, such
25    representation is made or appears or such a sign  is  allowed
26    to  remain  upon  or  in  such  a  place  of  business  shall
27    constitute a separate offense under this Act.
28        The  holder of any license or certificate of registration
29    shall conspicuously display it in the pharmacy in which he is
30    engaged  in  the  practice  of  pharmacy.    The   registered
31    pharmacist  in charge shall conspicuously display his name in
32    such  pharmacy.   The  pharmacy   license   shall   also   be
33    conspicuously displayed.
34    (Source: P.A. 89-507, eff. 7-1-97; 90-253, eff. 7-29-97.)
 
                            -13-           LRB9206282ACacam01
 1        (225 ILCS 85/17.1 new)
 2        (Section scheduled to be repealed on January 1, 2008)
 3        Sec. 17.1. Pharmacy technician training.
 4        (a)  Beginning  January  1,  2004,  it shall be the joint
 5    responsibility of a pharmacy and its pharmacist in charge  to
 6    have  trained all of its pharmacy technicians or obtain proof
 7    of prior training in all of  the  following  topics  as  they
 8    relate to the practice site:
 9             (1)  The   duties   and   responsibilities   of  the
10        technicians and pharmacists.
11             (2)  Tasks  and  technical  skills,  policies,   and
12        procedures.
13             (3)  Compounding, packaging, labeling, and storage.
14             (4)  Pharmaceutical and medical terminology.
15             (5)  Record keeping requirements.
16             (6)  The  ability  to  perform  and apply arithmetic
17        calculations.
18        (b)  Within 6 months after initial employment or changing
19    the duties and responsibilities of a pharmacy technician,  it
20    shall  be  the  joint  responsibility of the pharmacy and the
21    pharmacist in charge to  train  the  pharmacy  technician  or
22    obtain  proof  of  prior  training  in  the  areas  listed in
23    subsection (a) of this Section as they relate to the practice
24    site.
25        (c)  All  divisions  of  pharmacies  shall  maintain   an
26    up-to-date   training   program  describing  the  duties  and
27    responsibilities of a pharmacy technician.
28        (d)  All  divisions  of  pharmacies  shall   create   and
29    maintain retrievable records of training or proof of training
30    as required in this Section.

31        (225 ILCS 85/18) (from Ch. 111, par. 4138)
32        (Section scheduled to be repealed on January 1, 2008)
33        Sec.  18.  Record retention. There shall be kept in every
 
                            -14-           LRB9206282ACacam01
 1    drugstore or pharmacy a suitable book,  file,  or  electronic
 2    record  keeping  system  in  which  shall  be preserved for a
 3    period of not less than 5 years the original of every written
 4    prescription and the original transcript  or  copy  of  every
 5    verbal prescription filled, compounded, or dispensed, in such
 6    pharmacy; and such book or file of prescriptions shall at all
 7    reasonable  times  be  open  to  inspection  to  the pharmacy
 8    coordinator and the duly authorized agents  or  employees  of
 9    the Department.
10        Every  prescription  filled or refilled shall contain the
11    unique  identifier  of  the  person  authorized  to  practice
12    pharmacy under the provision of this Act who fills or refills
13    the prescription.
14        Records kept pursuant to this Section may  be  maintained
15    in  an  alternative  data  retention system, such as a direct
16    digital imaging system, provided that:
17             (1)  the records maintained in the alternative  data
18        retention  system contain all of the information required
19        in a manual record;
20             (2)  the  data  processing  system  is  capable   of
21        producing  a  hard  copy  of the electronic record on the
22        request  of  the  Board,  its  representative,  or  other
23        authorized local, State, or federal  law  enforcement  or
24        regulatory agency; and
25             (3)  the digital images are recorded and stored only
26        by  means  of a technology that does not allow subsequent
27        revision or replacement of the images.
28        As used in this Section, "digital imaging system" means a
29    system, including people, machines, methods of  organization,
30    and  procedures,  that  provides  input, storage, processing,
31    communications, output, and control functions  for  digitized
32    representations of original prescription records.
33        Inpatient   drug  orders  may  be  maintained  within  an
34    institution in a manner approved by the Department.
 
                            -15-           LRB9206282ACacam01
 1    (Source: P.A. 90-253, eff. 7-29-97.)

 2        (225 ILCS 85/19) (from Ch. 111, par. 4139)
 3        (Section scheduled to be repealed on January 1, 2008)
 4        Sec.  19.   Nothing  contained  in  this  Act  shall   be
 5    construed  to  prohibit  a  pharmacist licensed in this State
 6    from  filling  or  refilling   a   valid   prescription   for
 7    prescription drugs which is on file in a pharmacy licensed in
 8    any  state  and  has  been  transferred  from one pharmacy to
 9    another by any means, including by  way  of  electronic  data
10    processing   equipment  upon  the  following  conditions  and
11    exceptions:
12        (1)  Prior   to   dispensing   pursuant   to   any   such
13    prescription, the dispensing pharmacist shall:
14             (a)  Advise the patient  that  the  prescription  on
15        file  at  such  other pharmacy must be canceled before he
16        will be able to fill or refill it.
17             (b)  Determine that the prescription is valid and on
18        file at such other pharmacy and  that  such  prescription
19        may  be  filled  or refilled, as requested, in accordance
20        with  the   prescriber's   intent   expressed   on   such
21        prescription.
22             (c)  Notify  the  pharmacy where the prescription is
23        on file that the prescription must be canceled.
24             (d)  Record in writing the prescription  order,  the
25        name  of  the  pharmacy  at which the prescription was on
26        file, the prescription number, the name of the  drug  and
27        the  original  amount  dispensed,  the  date  of original
28        dispensing,  and  the  number  of  remaining   authorized
29        refills.
30             (e)  Obtain  the  consent  of  the prescriber to the
31        refilling of the prescription when the  prescription,  in
32        the  professional  judgment of the dispensing pharmacist,
33        so requires.   Any  interference  with  the  professional
 
                            -16-           LRB9206282ACacam01
 1        judgment  of  the  dispensing  pharmacist  by  any  other
 2        registered  pharmacist, his agents, or employees shall be
 3        grounds for revocation or suspension of the permit issued
 4        to the pharmacy.
 5        (2)  Upon  receipt  of   a   request   for   prescription
 6    information set forth in subparagraph (d) of paragraph (1) of
 7    this Section, if the requested pharmacist is satisfied in his
 8    professional  judgment  that such request is valid and legal,
 9    the requested pharmacist shall:
10             (a)  Provide   such   information   accurately   and
11        completely.
12             (b)  Record on the face of the prescription the name
13        of the requesting pharmacy and pharmacist and the date of
14        request.
15             (c)  Cancel the prescription on file by writing  the
16        word   "void"  on  its  face.   No  further  prescription
17        information  shall  be  given  or  medication   dispensed
18        pursuant to such original prescription.
19        (3)  In  the  event that, after the information set forth
20    in subparagraph (d) of paragraph (1) of this Section has been
21    provided, a prescription is not dispensed by  the  requesting
22    pharmacist, then such pharmacist shall provide notice of this
23    fact   to  the  pharmacy  from  which  such  information  was
24    obtained; such notice shall then cancel the  prescription  in
25    the same manner as set forth in subparagraph (c) of paragraph
26    (2) of this Section.
27        (4)  When  filling  or  refilling a valid prescription on
28    file in another state, the  dispensing  pharmacist  shall  be
29    required to follow all the requirements of Illinois law which
30    apply  to  the dispensing of prescription drugs.  If anything
31    in Illinois law prevents the  filling  or  refilling  of  the
32    original  prescription  it  shall  be  unlawful  to  dispense
33    pursuant to this Section.
34        (5)  Prescriptions  for drugs in Schedules III, IV, and V
 
                            -17-           LRB9206282ACacam01
 1    of the Illinois Controlled Substances Act may be  transferred
 2    only once and may not be further transferred.
 3    (Source: P.A. 88-428.)

 4        (225 ILCS 85/22) (from Ch. 111, par. 4142)
 5        (Section scheduled to be repealed on January 1, 2008)
 6        Sec.  22.  Except only in the case of a drug, medicine or
 7    poison which is lawfully sold or dispensed, at retail, in the
 8    original and unbroken package of the manufacturer, packer, or
 9    distributor thereof, and which  package  bears  the  original
10    label   thereon   showing   the   name  and  address  of  the
11    manufacturer, packer, or distributor thereof, and the name of
12    the drug, medicine, or  poison  therein  contained,  and  the
13    directions  for its use, no person shall sell or dispense, at
14    retail, any drug, medicine, or poison,  without  affixing  to
15    the  box,  bottle,  vessel, or package containing the same, a
16    label bearing the name of the article distinctly  shown,  and
17    the  directions for its use, with the name and address of the
18    pharmacy wherein the same is sold or dispensed.  However,  in
19    the  case  of  a  drug,  medicine, or poison which is sold or
20    dispensed pursuant to a prescription of a physician  licensed
21    to  practice  medicine  in  all  of  its  branches,  licensed
22    dentist,   licensed  veterinarian,  licensed  podiatrist,  or
23    therapeutically  or  diagnostically   certified   optometrist
24    authorized by law to prescribe drugs or medicines or poisons,
25    the  label  affixed  to  the  box, bottle, vessel, or package
26    containing the same shall show: (a) the name and  address  of
27    the  pharmacy  wherein the same is sold or dispensed; (b) the
28    name or  initials  of  the  person,  authorized  to  practice
29    pharmacy  under  the  provisions  of  this  Act,  selling  or
30    dispensing  the same, (c) the date on which such prescription
31    was filled; (d) the name  of  the  patient;  (e)  the  serial
32    number  of  such  prescription  as  filed in the prescription
33    files; (f) the last name of the practitioner  who  prescribed
 
                            -18-           LRB9206282ACacam01
 1    such  prescriptions;  (g)  the  directions for use thereof as
 2    contained in such prescription; and (h) the proprietary  name
 3    or  names  or the established name or names of the drugs, the
 4    dosage  and  quantity,  except  as  otherwise  authorized  by
 5    regulation of  the  Department.   Any  person  who  sells  or
 6    dispenses any drug, medicine or poison shall sell or dispense
 7    such  drug,  medicine or poison in good faith.  "Good faith",
 8    for purposes of this Section, has the meaning ascribed to  it
 9    in  subsection (u) of Section 102 of the "Illinois Controlled
10    Substances Act", approved August 16, 1971,  as  amended.  The
11    Department   shall  establish  rules  governing  labeling  in
12    Division II and Division III pharmacies.
13    (Source: P.A. 90-253, eff. 7-29-97.)

14        (225 ILCS 85/27) (from Ch. 111, par. 4147)
15        (Section scheduled to be repealed on January 1, 2008)
16        Sec. 27.  Fees.  The following fees are not refundable.
17    (A)  Certificate of pharmacy technician.
18             (1)  The fee for application for  a  certificate  of
19        registration as a pharmacy technician is $40.
20             (2)  The  fee  for  the  renewal of a certificate of
21        registration as a pharmacy technician shall be calculated
22        at the rate of $25 per year.
23    (B)  License as a pharmacist.
24             (1)  The fee for application for a license is $75.
25             (2)  In addition, applicants for any examination  as
26        a  registered pharmacist shall be required to pay, either
27        to the Department or to the designated testing service, a
28        fee covering  the  cost  of  determining  an  applicant's
29        eligibility  and  providing  the examination.  Failure to
30        appear for the examination on the scheduled date, at  the
31        time   and   place   specified,   after  the  applicant's
32        application  for  examination  has  been   received   and
33        acknowledged  by the Department or the designated testing
 
                            -19-           LRB9206282ACacam01
 1        service,  shall  result  in   the   forfeiture   of   the
 2        examination fee.
 3             (3)  The   fee   for   a  license  as  a  registered
 4        pharmacist registered  or  licensed  under  the  laws  of
 5        another state or territory of the United States is $200.
 6             (4)  The  fee upon the renewal of a license shall be
 7        calculated at the rate of $75 per year.
 8             (5)  The fee for the restoration  of  a  certificate
 9        other  than  from  inactive status is $10 plus all lapsed
10        renewal fees.
11             (6)  Applicants  for  the   preliminary   diagnostic
12        examination  shall  be  required  to  pay,  either to the
13        Department or to the designated testing  service,  a  fee
14        covering   the   cost   of   determining  an  applicant's
15        eligibility and providing the  examination.   Failure  to
16        appear  for the examination on the scheduled date, at the
17        time and  place  specified,  after  the  application  for
18        examination  has  been  received  and acknowledged by the
19        Department  or  the  designated  testing  service,  shall
20        result in the forfeiture of the examination fee.
21             (7)  The fee to have the scoring of  an  examination
22        authorized by the Department reviewed and verified is $20
23        plus any fee charged by the applicable testing service.
24    (C)  License as a pharmacy.
25             (1)  The  fee  for  application  for a license for a
26        pharmacy under this Act is $100.
27             (2)  The fee for the renewal  of  a  license  for  a
28        pharmacy  under  this Act shall be calculated at the rate
29        of $100 per year.
30             (3)  The    fee    for    the    change     of     a
31        pharmacist-in-charge is $25.
32    (D)  General Fees.
33             (1)  The   fee  for  the  issuance  of  a  duplicate
34        license, for the issuance of a replacement license for  a
 
                            -20-           LRB9206282ACacam01
 1        license  that  has  been  lost  or  destroyed  or for the
 2        issuance of a license with a change of  name  or  address
 3        other  than  during the renewal period is $20.  No fee is
 4        required for  name  and  address  changes  on  Department
 5        records when no duplicate certification is issued.
 6             (2)  The  fee  for a certification of a registrant's
 7        record for any purpose is $20.
 8             (3)  The fee to have the scoring of  an  examination
 9        administered  by  the Department reviewed and verified is
10        $20.
11             (4)  The  fee  for  a   wall   certificate   showing
12        licensure  or  registration  shall  be the actual cost of
13        producing the certificate.
14             (5)  The fee for a roster of persons  registered  as
15        pharmacists  or registered pharmacies in this State shall
16        be the actual cost of producing the roster.
17             (6)  The fee for pharmacy licensing, disciplinary or
18        investigative records obtained pursuant to a subpoena  is
19        $1 per page.
20        (E)  Except  as  provided  in  subsection (F), all moneys
21    received by the Department under this Act shall be  deposited
22    in  the  Illinois  State  Pharmacy  Disciplinary  Fund hereby
23    created in the State Treasury and shall be used only for  the
24    following purposes: (a) by the State Board of Pharmacy in the
25    exercise of its powers and performance of its duties, as such
26    use is made by the Department upon the recommendations of the
27    State  Board  of  Pharmacy, (b) for costs directly related to
28    license renewal of persons licensed under this Act,  and  (c)
29    for direct and allocable indirect costs related to the public
30    purposes of the Department of Professional Regulation.
31        Moneys  in the Fund may be transferred to the Professions
32    Indirect Cost Fund as authorized under  Section  2105-300  of
33    the  Department  of  Professional  Regulation  Law  (20  ILCS
34    2105/2105-300).
 
                            -21-           LRB9206282ACacam01
 1        The  moneys  deposited  in  the  Illinois  State Pharmacy
 2    Disciplinary Fund shall be invested to  earn  interest  which
 3    shall accrue to the Fund. The Department shall present to the
 4    Board  for  its review and comment all appropriation requests
 5    from the Illinois  State  Pharmacy  Disciplinary  Fund.   The
 6    Department  shall  give  due consideration to any comments of
 7    the Board in making appropriation requests.
 8        (F)  From the money received for license renewal fees, $5
 9    from each  pharmacist  fee,  and  $2.50  from  each  pharmacy
10    technician  fee, shall be set aside within the Illinois State
11    Pharmacy Disciplinary Fund for the purpose  of  supporting  a
12    substance   abuse   program   for  pharmacists  and  pharmacy
13    technicians. The State Board of Pharmacy shall,  pursuant  to
14    all  provisions  of  the Illinois Procurement Code, determine
15    how and to whom the money set aside under this subsection  is
16    disbursed.
17        (G)  (Blank).
18    (Source: P.A. 90-372, eff. 7-1-98; 91-239, eff. 1-1-00.)

19        (225 ILCS 85/30) (from Ch. 111, par. 4150)
20        (Section scheduled to be repealed on January 1, 2008)
21        Sec.  30.  (a) In accordance with Section 11 of this Act,
22    the Department may refuse to issue, restore, or renew, or may
23    revoke, suspend, place on probation, reprimand or take  other
24    disciplinary  action  as  the Department may deem proper with
25    regard to any license or certificate of registration for  any
26    one or combination of the following causes:
27             1.  Material  misstatement in furnishing information
28        to the Department.
29             2.  Violations of this Act, or the rules promulgated
30        hereunder.
31             3.  Making any misrepresentation for the purpose  of
32        obtaining licenses.
33             4.  A   pattern   of   conduct   which  demonstrates
 
                            -22-           LRB9206282ACacam01
 1        incompetence or unfitness to practice.
 2             5.  Aiding or assisting another person in  violating
 3        any provision of this Act or rules.
 4             6.  Failing, within 60 days, to respond to a written
 5        request made by the Department for information.
 6             7.  Engaging    in    dishonorable,   unethical   or
 7        unprofessional conduct of a character likely to  deceive,
 8        defraud or harm the public.
 9             8.  Discipline   by  another  U.S.  jurisdiction  or
10        foreign nation, if at least one of the  grounds  for  the
11        discipline  is  the  same  or substantially equivalent to
12        those set forth herein.
13             9.  Directly or indirectly giving  to  or  receiving
14        from   any  person,  firm,  corporation,  partnership  or
15        association any fee, commission, rebate or other form  of
16        compensation  for  any professional services not actually
17        or personally rendered.
18             10.  A finding by the Department that the  licensee,
19        after  having  his  license placed on probationary status
20        has violated the terms of probation.
21             11.  Selling or engaging in the sale of drug samples
22        provided at no cost by drug manufacturers.
23             12.  Physical illness, including but not limited to,
24        deterioration through the aging process, or loss of motor
25        skill which results in  the  inability  to  practice  the
26        profession with reasonable judgment, skill or safety.
27             13.  A  finding  that  licensure or registration has
28        been applied for or obtained by fraudulent means.
29             14.  The applicant, or licensee has  been  convicted
30        in  state or federal court of any crime which is a felony
31        or any misdemeanor related to the practice  of  pharmacy,
32        of which an essential element is dishonesty.
33             15.  Habitual  or  excessive  use  or  addiction  to
34        alcohol,  narcotics,  stimulants  or  any  other chemical
 
                            -23-           LRB9206282ACacam01
 1        agent or drug which results in the inability to  practice
 2        with reasonable judgment, skill or safety.
 3             16.  Willfully  making  or  filing  false records or
 4        reports in the practice of pharmacy, including,  but  not
 5        limited  to  false  records to support claims against the
 6        medical assistance program of the  Department  of  Public
 7        Aid under the Public Aid Code.
 8             17.  Gross and willful overcharging for professional
 9        services including filing false statements for collection
10        of  fees  for which services are not rendered, including,
11        but  not  limited  to,  filing   false   statements   for
12        collection  of  monies for services not rendered from the
13        medical assistance program of the  Department  of  Public
14        Aid under the Public Aid Code.
15             18.  Repetitiously   dispensing  prescription  drugs
16        without receiving a written or oral prescription.
17             19.  Upon a finding of a substantial discrepancy  in
18        a  Department  audit  of  a  prescription drug, including
19        controlled substances, as that term is  defined  in  this
20        Act or in the Illinois Controlled Substances Act.
21             20.  Physical illness which results in the inability
22        to practice with reasonable judgment, skill or safety, or
23        mental  incompetency  as declared by a court of competent
24        jurisdiction.
25             21.  Violation   of   the   Health    Care    Worker
26        Self-Referral Act.
27             22.  Failing to sell or dispense any drug, medicine,
28        or  poison in good faith.  "Good faith", for the purposes
29        of this Section,  has  the  meaning  ascribed  to  it  in
30        subsection  (u) of Section 102 of the Illinois Controlled
31        Substances Act.
32             23.  Interfering with the professional judgment of a
33        pharmacist by any registrant under this Act,  or  his  or
34        her agents or employees.
 
                            -24-           LRB9206282ACacam01
 1        (b)  The  Department  may  refuse to issue or may suspend
 2    the license or registration of any person who fails to file a
 3    return, or to pay the tax, penalty or  interest  shown  in  a
 4    filed  return, or to pay any final assessment of tax, penalty
 5    or interest, as required by any tax Act administered  by  the
 6    Illinois  Department  of  Revenue,  until  such  time  as the
 7    requirements of any such tax Act are satisfied.
 8        (c)  The  Department  shall   revoke   the   license   or
 9    certificate  of  registration  issued under the provisions of
10    this Act or any prior Act of this State of any person who has
11    been convicted a second time of committing any  felony  under
12    the  Illinois  Controlled  Substances  Act,  or  who has been
13    convicted a second time of committing a Class 1 felony  under
14    Sections  8A-3  and  8A-6 of the Illinois Public Aid Code.  A
15    person whose license or certificate  of  registration  issued
16    under  the  provisions  of  this Act or any prior Act of this
17    State  is  revoked  under  this  subsection  (c)   shall   be
18    prohibited  from engaging in the practice of pharmacy in this
19    State.
20        (d)  In any order issued in resolution of a  disciplinary
21    proceeding,  the  Board may request any licensee found guilty
22    of a charge involving a significant violation  of  subsection
23    (a)  of  Section  5,  or  paragraph  19  of  Section 30 as it
24    pertains to controlled substances, to pay to the Department a
25    fine not to exceed $2,000.
26        (e)  In any order issued in resolution of a  disciplinary
27    proceeding, in addition to any other disciplinary action, the
28    Board  may request any licensee found guilty of noncompliance
29    with the continuing education requirements of Section  12  to
30    pay the Department a fine not to exceed $1000.
31        (f)  The  Department shall issue quarterly to the Board a
32    status of all complaints related to the  profession  received
33    by the Department.
34    (Source: P.A. 86-596; 86-1434; 86-1472; 87-1207.)".

[ Top ]